Is the Combination Nirmatrelvir Plus Ritonavir Effective for Treating or Preventing COVID-19?

This article is the Russian translation of the Plain Language Summary (PLS) of the Cochrane Review previously published in the Cochrane Database of Systematic Reviews. Original publication: Reis S, Metzendorf M-I, Kuehn R, Popp M, Gagyor I, Kranke P, et al. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.Cochrane Database of Systematic Reviews 2022, Issue 9. Art. No.: CD015395. https://doi.org/10.1002/14651858. CD015395.pub2.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Безопасность и риск фармакотерапии - 10(2022), 4, Seite 434-435

Sprache:

Russisch

Beteiligte Personen:

article Editorial [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.risksafety.ru [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Cochrane review
Covid-19
Efficacy
Nirmatrelvir
Prevention
Ritonavir
Safety
Therapeutics. Pharmacology
Treatment

doi:

10.30895/2312-7821-2022-10-4-434-435

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ004479262